NCT03610126

Brief Summary

this study will be undertaken to compare the efficacy of BASKA mask in volume controlled and pressure controlled ventilation in laparoscopic cholecystectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
25 days until next milestone

Study Start

First participant enrolled

August 26, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2022

Completed
Last Updated

May 10, 2022

Status Verified

May 1, 2022

Enrollment Period

3.7 years

First QC Date

July 16, 2018

Last Update Submit

May 8, 2022

Conditions

Keywords

BASKA maskcontrolled ventilation

Outcome Measures

Primary Outcomes (1)

  • oropharyngeal leak pressure

    the oropharyngeal leak airway pressure will be used as a primary outcome to compare the efficacy of BASKA mask in volume controlled and pressure controlled ventilation in laparoscopic cholecystectomy and measuring leak pressure.

    Intra-operative

Secondary Outcomes (1)

  • End tidal carbon dioxide

    Intraoperative

Study Arms (2)

volume controlled ventilation

after induction of anesthesia and insertion of BASKA laryngeal mask airway mechanical ventilation of patients will be maintained with volume controlled ventilation mode

Procedure: volume controlled ventilation

pressure controlled ventilation

after induction of anesthesia and insertion of BASKA laryngeal mask airway and mechanical ventilation of patients will be maintained with pressure controlled ventilation mode

Procedure: pressure controlled ventilation

Interventions

the patients will be ventilated by volume controlled ventilation after insertion of the BASKA laryngeal mask airway

Also known as: volume controlled
volume controlled ventilation

the patients will be ventilated by pressure controlled ventilation after insertion of the BASKA laryngeal mask airway

Also known as: pressure controlled
pressure controlled ventilation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

ASA I\&II in the age range 18-60 years of both sexes and scheduled for elective laparoscopic cholecystectomy surgery

You may qualify if:

  • patients scheduled for elective cholecystectomy laparoscopic surgery.
  • Age: 18-60 years.
  • ASA physical status: I-II.

You may not qualify if:

  • Patient refusal.
  • History of cardiac disease, psychological disorders, respiratory diseases including asthma, renal or hepatic failure.
  • Patients who have high risk of regurgitation or aspiration based on history of gastro esophageal reflux, hiatus hernia, diabetes and gross obesity.
  • Neck pathology.
  • Patients who predicted difficult airway (based on a history of difficult airway, mouth opening was less than 2.5 cm, inter-incisor distance \< 20 mm, cervical spine pathology, modified Mallampati class III/IV, or thyromental distance \< 65 mm).
  • Preoperative sore throat.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university hospitals

Asyut, Assiut Governorate, Egypt,71571, Egypt

Location

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hala S Abdel-Ghaffar, MD

    Assiut university hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 16, 2018

First Posted

August 1, 2018

Study Start

August 26, 2018

Primary Completion

May 8, 2022

Study Completion

May 8, 2022

Last Updated

May 10, 2022

Record last verified: 2022-05

Locations